41 results
8-K
EX-10.1
ELTX
Elicio Therapeutics Inc.
2 Feb 24
Departure of Directors or Certain Officers
8:51am
by the Company. The Company’s rights under this Section 7 shall be full recourse. The Company shall have the right to offset Participant’s obligations … to transfer, offset, counterclaim or recoupment by any other amount unless otherwise permitted by Section 409A. (b) Notwithstanding any other payment
8-K/A
EX-99.2
d6cwgltmb9t hhnf
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.1
cids6db
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.5
rkub94eecpi
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
i7susrz18cm3kl
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
nzxjkwmkrl83ov5xrnh
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
u540pmiw
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
9r2p j30xc4k6zlnobr
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.25
7dwokefnqw4u0t1 wy4q
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.27
km07ml
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm